SEI Medical PCL

SEI Medical PCL FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of SEI Medical PCL (SEI.BK) as of Oct 25, 2026 is 76.50 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 75.85 % — a change of 0.85% (higher).

FCF Conversion

76.50 %

YoY

0.85%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of SEI Medical PCL is 2025 76.50 % . FCF Conversion Rate (FCF/EBITDA) of SEI Medical PCL was 2024 75.85 % . It decreases by 0.85% higher compared to the previous year.

The SEI Medical PCL FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2022
185.15 THB
Jan 1, 2023
-138.80 THB
Jan 1, 2024
75.85 THB
Jan 1, 2025
76.50 THB
The SEI Medical PCL FCF Conversion history
YEARFCF ConversionYoY
76.50 %+0.85%
75.85 %-154.65%
-138.80 %-174.97%
185.15 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

SEI Medical PCL Stock analysis

What does SEI Medical PCL do? SEI Medical PCL generates revenue through the distribution and leasing of medical equipment and laboratory instruments. The company's primary products include endoscopy equipment, surgical equipment, aesthetic equipment, neonatal care equipment, and laboratory equipment, sold across its Scientific equipment and medical equipment segments. Service contracts form another key revenue stream, covering maintenance and support for medical devices. The firm serves healthcare providers and institutions requiring diagnostic and treatment solutions, leveraging its Bangkok headquarters to operate within Thailand's medical sector. The company's business model focuses on selling scientific and medical equipment, offering service contracts, and providing medical equipment lease agreements. Its segments are clearly defined as Scientific equipment and medical equipment, with service as a separate offering. Revenue is derived from direct sales to hospitals, clinics, and laboratories, as well as from long-term lease contracts. The firm's IPO on September 24, 2024, marks its entry into public markets, though it continues to rely on its established distribution network for growth. SEI Medical PCL's core operations involve the sale of specialized medical equipment including endoscopy, surgical, and neonatal care devices, alongside laboratory instruments. The service segment provides essential maintenance and technical support, enhancing customer retention. The company targets healthcare facilities seeking comprehensive solutions for diagnostic and therapeutic procedures, positioning itself as a key supplier in Thailand's medical equipment market. SEI Medical PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SEI Medical PCL stock

FCF Conversion Rate (FCF/EBITDA) of SEI Medical PCL is 76.50 % in 2025.

FCF Conversion Rate (FCF/EBITDA) of SEI Medical PCL changed from 75.85 % to 76.50 %, representing a 0.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) SEI Medical PCL since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s SEI Medical PCL with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — SEI Medical PCL

All Key Metrics — SEI Medical PCL